ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664217 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664217; 2) Community: the network communities that were significantly associated with the response to NSC 664217; 3) Molecule: the relationships between components within communities and NSC 664217; 4) MDR: the compounds that were significantly associated with the NSC 664217.

NSC Compound Enrichment Correlation
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.00227238673876898 0.43774988
NSC 639505 Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride 0.00227238673876898 0.38886773
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.00227238673876898 0.42524787
NSC 726627 thiadiazines 0.002272386738769 0.39896196
NSC 762555 Null 0.002272386738769 -0.20363108
NSC 8120 Claviform 0.002272386738769 0.38565339
NSC 143095 Pyrazofurin 0.00293992674122322 0.36238186
NSC 294846 Cinnoline, 4-nitro-, 1-oxide 0.00293992674122322 0.28765944
NSC 605440 Isothiazolo[2,3-a]azepine, 5,7-bis(trifluoromethyl)- 2,3-dihydro-, 1,1-dioxide 0.00293992674122322 0.40600435
NSC 679005 2-Butenedioic acid, 2,2'-(2,4-dioxopyrimidine-1,3-diyl)bis-, tetraethyl ester 0.00293992674122322 0.30788867
Total:121  Current:17    [First] [Prev] [Next] [Last]